Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Microbes and infection

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.micinf.2009.07.009PMID 19647801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flavivirus Encephalitis

  2010cited by this paper
• To Live

  2010cited by this paper
• Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes.

  2008cited by this paper
• Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice.

  2007cited by this paper
• A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

  2007cited by this paper
• A live, attenuated recombinant West Nile virus vaccine.

  2006cited by this paper
• A structural perspective of the flavivirus life cycle

  2005cited by this paper
• Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus

  2005cited by this paper
• Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.

  2005cited by this paper
• Inefficient Signalase Cleavage Promotes Efficient Nucleocapsid Incorporation into Budding Flavivirus Membranes

  2004cited by this paper
• Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.

  2004cited by this paper
• Flavivirus encephalitis.

  2004cited by this paper
• Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone.

  2004cited by this paper
• Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

  2003cited by this paper
• Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus.

  2003cited by this paper
• Folding and Dimerization of Tick-Borne Encephalitis Virus Envelope Proteins prM and E in the Endoplasmic Reticulum

  2002cited by this paper
• Antibody Prophylaxis and Therapy for Flavivirus Encephalitis Infections

  2001cited by this paper
• Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.

  2001cited by this paper
• West Nile encephalitis: an emerging disease in the United States.

  2001influential reference
• A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

  2001cited by this paper
• A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice.

  2000cited by this paper
• A Single Intramuscular Injection of Recombinant Plasmid DNA Induces Protective Immunity and Prevents Japanese Encephalitis in Mice

  2000cited by this paper
• Mutagenesis of the NS2B-NS3-Mediated Cleavage Site in the Flavivirus Capsid Protein Demonstrates a Requirement for Coordinated Processing

  1999cited by this paper
• Mapping of Functional Elements in the Stem-Anchor Region of Tick-Borne Encephalitis Virus Envelope Protein E

  1999cited by this paper
• Induction of Protective Immunity against Japanese Encephalitis in Mice by Immunization with a Plasmid Encoding Japanese Encephalitis Virus Premembrane and Envelope Genes

  1998cited by this paper
• Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.

  1994cited by this paper
• NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies

  1994cited by this paper
• Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

  1993cited by this paper
• Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein

  1993cited by this paper
• Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

  1992cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• A Focus Assay Method for Japanese Encephalitis Virus Using Complement and Anti‐Virus Serum

  1985cited by this paper

• SARS‐CoV‐2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines

  2023influential citation
• Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.

  2021cites this paper
• Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines

  2020cites this paper
• Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice

  2020cites this paper
• The valosin-containing protein is implicated in West Nile virus replication and an examination of the pathogenicity of novel WNV strain isolated in Zambia [an abstract of dissertation and a summary of dissertation review]

  2018cites this paper
• Diagnostic aptitude of West Nile virus-like particles expressed in insect cells.

  2018cites this paper
• Development of a rapid and quantitative method for the analysis of viral entry and release using a NanoLuc luciferase complementation assay.

  2018influential citation
• Virus del Nilo Occidental en Ecuador

  2018cites this paper
• Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector.

  2016cites this paper
• Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

  2016cites this paper
• Valosin-containing protein (VCP/p97) plays a role in the replication of West Nile virus

  2016cites this paper
• Persistence of West Nile virus.

  2015cites this paper
• Establishment of tracking system for West Nile virus entry and evidence of microtubule involvement in particle transport.

  2014cites this paper
• Diagnostic Potential and Antigenic Properties of Recombinant Tick-Borne Encephalitis Virus Subviral Particles Expressed in Mammalian Cells from Semliki Forest Virus Replicons

  2013cites this paper
• Functional Analysis of Host Cell Proteins and Stress Responses that Inhibit West Nile Virus Infection

  2011cites this paper
• Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column.

  2011cites this paper
• Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice

  2010cites this paper
• Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced by Spodoptera frugiperda Cells for Use as Vaccine and Diagnostic Antigens

  2010influential citation
• Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.

  2010cites this paper